These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice. Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294 [TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [TBL] [Abstract][Full Text] [Related]
9. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. Chan OT; Madaio MP; Shlomchik MJ J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951 [TBL] [Abstract][Full Text] [Related]
10. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation of tubular epithelial interleukin-12 in autoimmune MRL-Fas(lpr) mice with renal injury. Fan X; Oertli B; Wüthrich RP Kidney Int; 1997 Jan; 51(1):79-86. PubMed ID: 8995720 [TBL] [Abstract][Full Text] [Related]
12. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice. Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682 [TBL] [Abstract][Full Text] [Related]
14. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251 [TBL] [Abstract][Full Text] [Related]
15. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117 [TBL] [Abstract][Full Text] [Related]
16. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. Boswell JM; Yui MA; Endres S; Burt DW; Kelley VE J Immunol; 1988 Jul; 141(1):118-24. PubMed ID: 3259964 [TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on the hyperresponsiveness to IL-18 in autoimmune MRL/MPJ-lpr/lpr mice. Furuya Y; Kawakita T; Nomoto K Int Immunopharmacol; 2003 Mar; 3(3):365-73. PubMed ID: 12639814 [TBL] [Abstract][Full Text] [Related]
19. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice. Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801 [TBL] [Abstract][Full Text] [Related]